Branched Chain Amino Acids BCAAs to Promote Recovery in Adolescents and Young Adults After Concussion A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
Led by Akiva Cohen · Updated on 2026-09-03
150
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of branched chain amino acids BCAAs on recovery from concussion in adolescents and young adults aged 11 to 23 years. This randomized, placebo-controlled, double-blinded clinical trial aims to determine if high-dose BCAAs can promote concussion recovery by comparing them to a placebo. The study builds on previous findings showing a reduction of BCAAs in the brain after injury and potential cognitive improvements with BCAA supplementation.
Participants will be randomly assigned to receive either a powder formulation containing the three BCAAs valine, isoleucine, and leucine or a placebo formulation designed to match the BCAA powder in taste, texture, and appearance. The treatment is administered daily to assess its impact on concussion recovery. The study period includes a treatment phase lasting 28 days post-injury.
Throughout the study, participants will be monitored closely through clinical and symptom assessments, including concussion symptom levels, visio-vestibular function, pupillary light reflex measurements, sleep quality, and physical activity. The main outcome is the number of participants meeting recovery criteria at 28 days, defined as returning to baseline symptom levels and feeling over 90% back to normal. Safety and adherence will be monitored, with study completion expected by December 2027.
CONDITIONS
Brief Title
BCAAs in Concussion 3.0
Research Team
O
Olivia E. Podolak
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
BCAAs (investigational)
Placebo (trial control)
Standard concussion care (context)
what it is
Oral powder containing a combination of the three branched‑chain amino acids taken at a high daily dose
Oral powder matching taste, texture and appearance but without active amino acids
Individualized active recovery including symptom‑guided return to activity, education, and multidisciplinary support
role in trial
Investigational treatment arm
Randomized control comparator
Contextual reference to guideline‑based usual concussion care
primary use
Aimed to promote faster recovery from concussion symptoms
Control arm to evaluate effects of BCAAs versus no active supplement
Support recovery through education, monitoring symptoms, and gradual return to activities
how it is given or performed
Daily oral powder combining three BCAAs
Daily oral powder matching the study product without active ingredients
Delivered through clinical guidance, educational materials and multidisciplinary follow‑up
evidence status
Under investigation; efficacy for concussion recovery not yet established
Serves as comparator; no therapeutic effect expected
Widely endorsed approach shown in guidelines to support recovery
important risks
Safety and tolerability being evaluated in the trial
Minimal risk assumed for inert placebo formulation
No significant risks expected when delivered per guidelines
important limitations
Unproven efficacy; unknown if benefits exceed standard care
No therapeutic effect; only acts as control
Guideline‑based care may vary by access, symptom complexity and provider availability
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 11Years - 23Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Males and females aged 11 to 23 years
Weigh at least 40 kilograms
Meet concussion criteria from the American Congress of Rehabilitative Medicine with one or more clinical signs or two or more acute symptoms including at least one visio-vestibular examination abnormality
Present within 4 days of concussion injury
Post-menarchal females must have a negative urine pregnancy test
Provide informed consent; for participants under 18, both parental consent and child assent are required
You will not qualify if you...
Evidence of moderate or severe traumatic brain injury, including Glasgow Coma Scale below 13, hospital admission, or neurosurgical intervention
Prior concussion or traumatic brain injury within the last 90 days
Known personal or family history of maple syrup urine disease
Use of any investigational drug within 30 days before enrollment
Participants who are pregnant, planning pregnancy during the study, or breastfeeding
Non-English speaking participants or parent/guardian
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 28 days
Participants receive either the BCAA powder or placebo daily to assess their effects on concussion recovery.
Regular visits during the 28-day treatment period
Follow-up
Duration - Up to 28 days post-injury
Participants are monitored to evaluate recovery progress through symptom assessments, vision and balance tests, and pupil response measurements.
Assessments at baseline and 28 days post-injury
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study of Active Rehabilitation to Improve Recovery After Mild Traumatic Brain Injury in Military Service Members at Fort Bragg
Branched Chain Amino Acids BCAAs to Promote Recovery in Adolescents and Young Adults After Concussion A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
Comparing Telemedicine Cognitive Behavioral Therapy and Mindfulness Treatment for Insomnia and Post-Traumatic Stress in Adults with Mild to Moderate Traumatic Brain Injury
Treatment Study of Personalized Augmented Cognitive Training with Intermittent Theta Burst Stimulation for Depression After Mild Traumatic Brain Injury in Adults
Improving Care for Youth Ages 11-18 with Persistent Post-Concussion Symptoms Using Behavioral Therapy and Parent Support
Effect of Creatine Supplementation on Recovery After Concussion in Adults Aged 18 to 35
Study of Balance and Dizziness Caused by Visual Patterns in Adults With Concussion or Other Dizziness Causes
Standardizing Ecological Cognitive Tests for Assessing Concussions in Male Football Players in France
Exercise Effects on Brain Function in Neurological Disorders Using Cardiopulmonary Testing and MRI
Evaluating Group-Based Emotional Awareness and Expression Therapy to Support Recovery After Acquired Brain Injury
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults.
Daniel J Corwin, Sage R Myers, Kristy B Arbogast...